Processing .....please wait.. 
The article has been forwarded.... 
News >> Technology >>
Ambit Biosciences appoints Shripad Bhagwat senior VP
By siliconindia
|
Monday, 07 March 2005, 20:30 IST
SAN DIEGO, CA: Ambit Biosciences Corp. has appointed Shripad Bhagwat as senior vice president of drug discovery. Bhagwat will manage the identification and pre clinical development of drugs identified by Ambits screening technologies.
Bhagwat fills the new position created as Ambit prepares to advance its lead drug candidate, a small molecule neuroprotectant for the treatment of stroke and other CNS disorders, into the clinic.
Before joining Ambit, Bhagwat worked as vice president of drug discovery at Celgene Corp. Bhagwat also worked as director of medicinal chemistry for Signal Pharmaceuticals. He has also held drug discovery positions at Abbott Laboratories and Ciba-Geigy Corp.
Ambit is a biopharmaceutical company developing small molecule neuroprotectants for the treatment of stroke and other CNS disorders and kinase inhibitors for the treatment of cancer and inflammation. A preclinical stroke program is expected to enter the clinic by the end of the year and an oncology program will go into the clinic in early 2006.
Founded in May 2000, Ambit currently has 40 employees and is expanding its medicinal chemistry team.